Terms: = Head and neck cancer AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11 AND Treatment
5 results:
1. Long-term Oncologic Outcomes of 1188 Tis-T2 Glottic cancers Treated by Transoral Laser Microsurgery.
Piazza C; Paderno A; Del Bon F; Lancini D; Fior M; Berretti G; Bosio P; Deganello A; Peretti G
Otolaryngol Head Neck Surg; 2021 Aug; 165(2):321-328. PubMed ID: 33400625
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes in patients with recurrent human papillomavirus-positive oropharyngeal cancer after upfront transoral robotic surgery.
Su W; Rajeev-Kumar G; Kang M; Posner M; Liu JT; Westra W; Miles BA; Gupta V; Sharma S; Misiukiewicz K; Genden E; Bakst RL
Head Neck; 2020 Dec; 42(12):3490-3496. PubMed ID: 32776411
[TBL] [Abstract] [Full Text] [Related]
3. The molecular markers of cancer stem cells in head and neck tumors.
Yu SS; Cirillo N
J Cell Physiol; 2020 Jan; 235(1):65-73. PubMed ID: 31206697
[TBL] [Abstract] [Full Text] [Related]
4. Expression of homeobox genes in oral squamous cell carcinoma cell lines treated with all-trans retinoic acid.
Acquafreda T; Nunes FD; Soprano DR; Soprano KJ
J Cell Biochem; 2010 Dec; 111(6):1437-44. PubMed ID: 20830740
[TBL] [Abstract] [Full Text] [Related]
5. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract] [Full Text] [Related]
